Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet...

Area of Science:

• Cardiology
• Interventional Cardiology
• Pharmacology

Background:

• Percutaneous coronary intervention (PCI) carries risks of major adverse cardiac events (MACE).
• The efficacy of cangrelor, an intravenous antiplatelet agent, was previously established in the CHAMPION PHOENIX trial.
• Patient outcomes may vary based on the complexity of coronary artery anatomy treated during PCI.

Purpose of the Study:

• To evaluate whether the effectiveness of cangrelor during PCI differs between patients with simple versus complex target lesion coronary anatomy.
• To analyze the impact of high-risk features in coronary lesions on MACE rates.
• To compare the safety and efficacy of cangrelor against clopidogrel in diverse patient subgroups.

Main Methods:

• Angiographic analysis of 10,854 patients from the CHAMPION PHOENIX trial.
• Classification of target lesions based on the presence of high-risk features (e.g., bifurcation, thrombus, calcification).
• Comparison of 48-hour MACE rates between cangrelor and clopidogrel, stratified by lesion complexity and patient presentation (ACS vs. SIHD).

Main Results:

• MACE rates increased progressively with the number of high-risk lesion features in clopidogrel-treated patients.
• Cangrelor demonstrated a consistent 21% reduction in 48-hour MACE compared to clopidogrel (4.7% vs. 5.9%), irrespective of lesion complexity (Pinteraction=0.66).
• High-risk lesion characteristics and cangrelor treatment were independent predictors of MACE; major bleeding rates were not increased by cangrelor.

Conclusions:

• Peri-procedural MACE after PCI is significantly influenced by the number of treated high-risk target lesion features.
• Cangrelor reduces MACE within 48 hours post-PCI in patients with stable ischemic heart disease or acute coronary syndrome, regardless of lesion complexity.
• The benefit-risk profile of cangrelor is particularly favorable in patients undergoing PCI for complex coronary anatomy.